| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |